However, in P53-mutant cancer cells, ME2 enhances the production of the “oncometabolite” 2-HG and prevents MDM2-mediated P53 degradation by binding to mutant P53, facilitating P53 mutant-driven tumor growth [68]. Here, TP53 is linked to cancer.